Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05121168 · ClinicalTrials.gov registry record · Phase 4

Continuous Erector Spinae Plane Blocks to Treat Pain Following Percutaneous Nephrolithotomy

A Phase 4 study of Pain, Acute Postoperative and Renal Stone, sponsored by University of California, San Diego.

Completed
Registry status
Phase 4
Development phase
50
Enrollment target
2
Study locations

NCT05121168 is a Phase 4 study of Pain, Acute Postoperative and Renal Stone that has completed, run by University of California, San Diego. The registered enrollment target is 50 participants. The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05121168, a Phase 4 study of Pain, Acute Postoperative and Renal Stone, has completed, sponsored by University of California, San Diego.

COMPLETED
Registry status
Phase 4
Development phase
50 participants
Enrollment target
2
Study locations

Study Summary

This is a randomized, triple-masked, placebo-controlled parallel-arm human subjects clinical trial investigating the addition of a continuous erector spinae plane nerve block to a single-injection erector spinae plane block to provide postoperative analgesia following percutaneous nephrolithotomy. Participants will all receive a single-injection nerve block and perineural catheter insertion. Following surgery, participants will be randomly allocated to receive either perineural local anesthetic or normal saline until the second day following surgery.

Interventions

  • DRUG Active bupivacaine 0.25% via an erector spinae plane perineural catheter
  • DRUG Placebo normal saline via an erector spinae plane perineural catheter

Study Locations (2)

California

  • UC San Diego - San Diego
  • University of California, San Diego - San Diego

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2022-03-16
Est. Completion 2025-11-08
Phase Phase 4

Sponsor

University of California, San Diego

775 total trials

What the Registry Record Tells You About NCT05121168

The ClinicalTrials.gov registry entry for NCT05121168 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Pain, Acute Postoperative appearing as the primary indexed condition, and to 2 interventions - of which Active bupivacaine 0.25% via an erector spinae plane perineural catheter is the first listed.

NCT05121168 reports 2 study locations spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05121168 about?

NCT05121168 is a clinical study titled "Continuous Erector Spinae Plane Blocks to Treat Pain Following Percutaneous Nephrolithotomy". This is a randomized, triple-masked, placebo-controlled parallel-arm human subjects clinical trial investigating the addition of a continuous erector spinae plane nerve block to a single-injection erector spinae plane block to provide postoperative analgesia following percutaneous nephrolithotomy. P...

What is the current status of trial NCT05121168?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2022-03-16. Estimated completion is 2025-11-08.

What conditions does trial NCT05121168 study?

This clinical trial studies the following conditions: Pain, Acute Postoperative, Renal Stone.

What interventions are being tested in trial NCT05121168?

The interventions under investigation include: Active bupivacaine 0.25% via an erector spinae plane perineural catheter (DRUG), Placebo normal saline via an erector spinae plane perineural catheter (DRUG).

Who is sponsoring clinical trial NCT05121168?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05121168 being conducted?

This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.